JSM 2004 - Toronto

Abstract #300406

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2004 Program page



Activity Number: 184
Type: Topic Contributed
Date/Time: Tuesday, August 10, 2004 : 8:30 AM to 10:20 AM
Sponsor: Section on Statistics in Epidemiology
Abstract - #300406
Title: Two-stage Designs for Population-based Association Studies
Author(s): Jaya M. Satagopan*+ and E. S. Venkatraman and Colin B. Begg
Companies: Memorial Sloan-Kettering Cancer Center and Memorial Sloan-Kettering Cancer Center and Memorial Sloan-Kettering Cancer Center
Address: Department of Epidemiology and Biostatistics, New York, NY, 10021,
Keywords: order statistic ; power ; optimal design
Abstract:

Gene-disease association studies based on case-control designs are used to identify candidate polymorphisms conferring disease risk. Here we propose a two-stage approach to identify disease susceptibility markers. In the first stage all markers are evaluated on a fraction of the available subjects. The most promising markers are further evaluated in Stage 2 on the remaining individuals. Using simulations, we show that this approach provides a substantial reduction in the total number of marker evaluations for a minimal loss of power in comparison with a one-stage approach (where all the candidate markers are evaluated on all the individuals). As a general guideline, the simulations indicate that evaluating all the markers on 50% of the individuals in Stage 1 and evaluating the most promising 10% of the markers on the remaining individuals in Stage 2 provides near optimal power while resulting in a 45% decrease in the total number of marker evaluations.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2004 program

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004